Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

[Prevention of recurrent thromboembolisms: WARFASA (aspirin for the prevention of recurrent venous thromboembolism - the Warfarin and Aspirin Study)].

Duerschmied D, Nitschmann S, Bode C.

Internist (Berl). 2013 Nov;54(11):1393-6. doi: 10.1007/s00108-013-3377-6. German. No abstract available.

PMID:
24045645
2.

An aspirin a day to keep the clots away: can aspirin prevent recurrent thrombosis in extended treatment for venous thromboembolism?

Wakefield TW, Obi AT, Henke PK.

Circulation. 2014 Sep 23;130(13):1031-3. doi: 10.1161/CIRCULATIONAHA.114.012235. Epub 2014 Aug 25. No abstract available.

3.

Aspirin and the prevention of venous thromboembolism.

Becker RC.

N Engl J Med. 2012 May 24;366(21):2028-30. doi: 10.1056/NEJMe1201911. No abstract available.

PMID:
22621631
4.

Aspirin for preventing the recurrence of venous thromboembolism.

Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P; WARFASA Investigators.

N Engl J Med. 2012 May 24;366(21):1959-67. doi: 10.1056/NEJMoa1114238. Erratum in: N Engl J Med. 2012 Oct 18;367(16):1573.

5.

The reemergence of aspirin for the prevention of venous thromboembolism.

Eikelboom J.

Clin Adv Hematol Oncol. 2012 Feb;10(2):120-1. No abstract available.

PMID:
22402355
6.

[Does aspirin still play a role in secondary prevention of venous thromboembolism?].

Pernod G.

J Mal Vasc. 2013 Feb;38(1):2-3. doi: 10.1016/j.jmv.2012.12.003. Epub 2013 Jan 21. French. No abstract available.

PMID:
23347567
7.

Aspirin in secondary prevention of recurrent venous thromboembolism.

Boonyawat K, Crowther MA.

J Thromb Thrombolysis. 2015 Apr;39(3):392-4. doi: 10.1007/s11239-015-1196-4. Review. No abstract available.

PMID:
25740464
8.

Aspirin for prevention of thromboembolism recurrence.

Heit JA.

N Engl J Med. 2012 Sep 13;367(11):1067-8; author reply 1068-9. doi: 10.1056/NEJMc1207382#SA3. No abstract available.

PMID:
22970960
9.

Aspirin for prevention of thromboembolism recurrence.

van de Meerendonk HW.

N Engl J Med. 2012 Sep 13;367(11):1067; author reply 1068-9. doi: 10.1056/NEJMc1207382#SA2. No abstract available.

PMID:
22970959
10.

Aspirin for prevention of thromboembolism recurrence.

Edwards C, Taylor S.

N Engl J Med. 2012 Sep 13;367(11):1067; author reply 1068-9. doi: 10.1056/NEJMc1207382#SA1. No abstract available.

PMID:
22970958
11.

ACP Journal Club: after initial anticoagulation for a first unprovoked venous thromboembolism, aspirin reduced recurrence.

Dunn A.

Ann Intern Med. 2015 Feb 17;162(4):JC5. doi: 10.7326/ACPJC-2015-162-4-005. No abstract available.

PMID:
25686192
12.

[Aspirin and prevention of thromboembolism: the next chapter of a long story].

Ferrières C, Conard J, Blacher J.

J Mal Vasc. 2013 Feb;38(1):4-5. doi: 10.1016/j.jmv.2012.12.001. Epub 2013 Jan 11. French. No abstract available.

PMID:
23317999
13.

Aspirin for dual prevention of venous and arterial thrombosis.

Warkentin TE.

N Engl J Med. 2012 Nov 22;367(21):2039-41. doi: 10.1056/NEJMe1211480. Epub 2012 Nov 4. No abstract available.

PMID:
23121404
14.

[Aspirin for preventing the recurrence of venous thromboembolism].

Lazareth I.

J Mal Vasc. 2013 Feb;38(1):1. doi: 10.1016/j.jmv.2012.12.002. Epub 2013 Jan 22. French. No abstract available.

PMID:
23351436
15.

Aspirin given for up to 2 years after initial anticoagulant treatment reduces the risk of venous thromboembolism recurrence without increasing risk of major bleeding.

Watson HG.

Evid Based Nurs. 2013 Jul;16(3):92-3. doi: 10.1136/eb-2012-100896. Epub 2012 Nov 23. No abstract available.

PMID:
23178311
16.

Re: Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?

White RH, Meehan JP, Romano PS.

J Arthroplasty. 2010 Jun;25(4):667; author reply 667-8. doi: 10.1016/j.arth.2009.10.017. Epub 2010 Jan 22. No abstract available.

PMID:
20097038
17.

Aspirin can continue to reduce blood clot risk after anticoagulants for venous thromboembolism, study finds.

Torjesen I.

BMJ. 2014 Aug 25;348:g5300. doi: 10.1136/bmj.g5300. No abstract available.

PMID:
25161278
18.

SCIP: VTE prevention controversy.

Mathias JM.

OR Manager. 2009 Aug;25(8):14, 16, 18. No abstract available.

PMID:
19725218
19.

A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty.

Intermountain Joint Replacement Center Writing Committee.

J Arthroplasty. 2012 Jan;27(1):1-9.e2. doi: 10.1016/j.arth.2011.03.032. Epub 2011 May 31.

PMID:
21621959
20.

Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid.

Undas A, Brummel-Ziedins K, Mann KG.

J Thromb Haemost. 2014 Nov;12(11):1776-87. doi: 10.1111/jth.12728. Epub 2014 Oct 15. Review.

Supplemental Content

Support Center